Clinical Trials Directory

Trials / Completed

CompletedNCT06316206

The Use of Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation

The Use of Ethinylestradiol/Dienogest in Random Start Rapid Preparation of Endometrium Before Office Hysteroscopic Polypectomies: a Multicenter, Prospective, Randomized Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
80 (actual)
Sponsor
University of Palermo · Academic / Other
Sex
Female
Age
45 Years
Healthy volunteers
Accepted

Summary

The presence of a thin endometrium plays an important role in enabling the best conditions for hysteroscopic surgery. Recently, for this purpose, many studies have evaluated the effect of preoperative administration of a variety of drugs. We explored the efficacy of random started 14-day administration of Ethinylestradiol/Dienogest, in rapid preparation of endometrium for hysteroscopic polypectomy.

Conditions

Interventions

TypeNameDescription
DRUGEthinylestradiol/Dienogest 0.03mg/2mgEndometrial polyps underwent hysteroscopic polipectomy after starting 14-day treatment with oral Ethinylestradiol/Dienogest 0.03mg/2mg at any time of the menstrual cycle

Timeline

Start date
2023-01-01
Primary completion
2023-08-01
Completion
2024-03-01
First posted
2024-03-18
Last updated
2024-04-22

Locations

2 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT06316206. Inclusion in this directory is not an endorsement.

The Use of Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation (NCT06316206) · Clinical Trials Directory